Effects of Static Stretching and Dynamic in Flexibility and Performance: Blind and Randomized Clinical Trial

Sponsor
Germanna de Medeiros Barbosa (Other)
Overall Status
Completed
CT.gov ID
NCT02689544
Collaborator
(none)
45
3
6

Study Details

Study Description

Brief Summary

The purpose of this study is analyze the effects, acute and chronic, static and dynamic stretching on flexibility and neuromuscular and functional performance in active, healthy individuals.

Study hypothesis:
  1. Static stretching program improves flexibility and reduces neuromuscular and functional performance in active, healthy individuals.

  2. Static stretching program improves flexibility and neuromuscular and functional performance in active, healthy individuals.

Condition or Disease Intervention/Treatment Phase
  • Other: intervention with static stretching
  • Other: intervention with Dynamic Stretching
  • Other: Control
N/A

Detailed Description

It is a randomized, blinded clinical trial where the first researcher (P1) was responsible for assessments and reassessments; the second searcher (P2) at randomization and inquiry of the subjects in the intervention protocol and the third investigator (P3) for the statistical analyzes.The research was conducted at the Laboratory of therapeutic practices of the Department of Physical Therapy, Federal University of Rio Grande do Norte (UFRN) and started after the approval of the ethics committee.The sample was recruited by convenience by written disclosure, electronics and personal contact in academies and higher education institutions in the city of Natal / RN. The volunteers were randomly distributed through the electronic site http://www.randomization.com (Code: 21318). Two pieces of information were inserted, namely: the sample size and the number of groups. With this data, the site has generated a specific encoding for each group and distributed the subjects randomly into three groups: static stretching (gAE); dynamic stretching (gAD) and control (gC).

Sample size calculation

For the sample size calculation was used G * Power 3.1.0 software and the procedures followed the recommendations of studies prévios45. Based on a pilot study of four volunteers, it has adopted a power of 0.95, considering a significance level of 5%, a correlation coefficient of 0.5, and 0.25 effect size for both, It calculated a "n" sample of 15 individuals for each group ("n" sample = 45). This analysis was performed to reduce the chance of Type II error and to determine the minimum number of individuals required for this investigation. Thus, the sample size was sufficient to provide 95.5% statistical power.

Procedures and evaluation measures

At first all subjects were recorded in the survey through an evaluation form containing information on identification, weight, height, injury history and physical activity .

After the process of randomization and allocation held by P2, the volunteers underwent the first evaluation (AV1) under the instruction of P1. This evaluation was performed at least 48 hours before the 1st stretching session to prevent possible residual effects of isokinetic and functional testing. Other evaluations AV2, AV3 and AV4, were made immediately after the 1st (acute response) and 10th sessions (acute post elongation) and 48 hours after the last (residual chronic response), respectively, for EAG and GAD. Already the subject of gc were subject only to the four evaluation processes, where the last assessment (AV4) coincided with the time related to the stretching protocol of the experimental groups. Despite receiving the same guidelines of the other groups on the importance of stretching activities routines during the study period the volunteers were told they should not perform stretching in the day-to-day.

All had non-dominant leg (MND) tested for flexibility, neuromuscular performance (muscle latency time and isokinetic performance) and functional performance (functional tests) in all four assessments. The MND was used because it is considered less skilled and more trainable, when compared to the MD46. For their identification was asked which member preferred to kick a bola15. However, during the interventions in the experimental groups (GAE, GAD), both members were elongated, evaluating the pain sensation at the end of each session and at the end of the intervention protocols, sensory perception (pleasure / displeasure) in performing elongation. The day of the period in which prevailed the assessments and reassessments was on afternoon shift.

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Acute and Chronic Effects of Static and Dynamic Stretching on Flexibility and Neuromuscular and Functional Performance in Healthy Subjects: a Blinded and Randomized Clinical Trial
Study Start Date :
Jun 1, 2015
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: static stretching

Group of 15 volunteers (gSS)

Other: intervention with static stretching
Members of static stretching group performed three sets of 30 second self hamstring stretch (IT) of both lower limbs, with 30 seconds of rest between sets, totaling 3 minute intervention so.

Experimental: dynamic stretching

Group of 15 volunteers (gDS)

Other: intervention with Dynamic Stretching
Each subject contracting antagonist muscle (quadriceps) to the target muscle (hamstring), performing dynamic movements of hip flexion with the knee extended, repeated every 1 second. They amounted to 3 of 30 repetitions completing approximately three minutes of dynamic stretching for each lower.

Other: control

Group of 15 volunteers (gC)

Other: Control
The control group volunteers no received intervention

Outcome Measures

Primary Outcome Measures

  1. Range of Motion [Evaluation of range of motion after one month the application of stretching]

    Range of Motion measured by Universal Goniometer

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 28 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • (1) male;

(2) were aged between 18 and 28 years old;

(3) Body mass index (BMI) of 21 to 25 kg / m2,

(4) not be participating in lower limb stretching programs;

(5) be healthy, according to Physical Activity Readiness Questionnaire (PAR-Q) and perform physical activity (recreational, not competitive level) for at least 3 times a week, according to the International Physical Activity Questionnaire (IPAQ)

(6) no history of injury or disease in the lower limbs in the last six months, without previous surgery in this segment;

(7) lack of musculoskeletal, cardiorespiratory and neurological disorders that prevent the completion of the evaluation and treatment protocols;

(8) is not under the effect of medicines that cause muscle relaxation or that inhibit muscle tonic action

(9) has ROM limitation (degree of muscle shortening) of at least 15 ° of active extension of joelho21, the non-dominant leg (considering 180 the full extent with hip positioned at 90 ° of flexion).

Exclusion Criteria:
  • (1) start stretching practice in daily activities during the study period;

(2) not perform evaluative and intervention procedures;

(3) absence of at least one of the sessions of stretching protocol;

(4) appearance of lesions during the period in which the subject is inserted in the survey;

(5) withdrawal in the study. Thus, it excluded eight volunteers, three per occurrence of injuries during the study period and five per withdrawal, concluding the study with a total of 45 subjects.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Germanna de Medeiros Barbosa

Investigators

  • Principal Investigator: Wouber H Vieira, Prof.Dr., Universidade Federal do Rio Grande do Norte

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Germanna de Medeiros Barbosa, Federal University of Rio Grande do Norte, Universidade Federal do Rio Grande do Norte
ClinicalTrials.gov Identifier:
NCT02689544
Other Study ID Numbers:
  • 1.132.671
First Posted:
Feb 24, 2016
Last Update Posted:
Feb 24, 2016
Last Verified:
Feb 1, 2016
Keywords provided by Germanna de Medeiros Barbosa, Federal University of Rio Grande do Norte, Universidade Federal do Rio Grande do Norte
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 24, 2016